96X-31047-52466
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-29
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tirednessFree text: Pain in the ipsilateral axila of the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-02
- 2021-01-04
- 2021-01-11
- 2021-01-18
- 2021-01-25
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-07
- 2021-02-14
- 2021-02-19
- 2021-02-26
-
2021-03-07
Survey response — day 35, dose 2MedDRA: Migraine, Pre-existing disease — Feeling: GoodFree text: Increased frequency of migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy - plannedMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-31
Survey response — 12 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: I gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-01-31
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Pain in the ipsilateral axila of the injection site
Release 5 — day 35, dose 2
Symptoms: Increased frequency of migraines
Release 9 — 6 months, dose 2
Symptoms: Pregnancy - planned
Release 11 — 12 months, dose 2
Symptoms: I gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release